Document is current
Any future updates will be listed below
-
Authors
Shakeel, Mohammed K.
Metzak, Paul D.
Lasby, Mike
Long, Xiangyu
Souza, Roberto
Bray, Signe
Goldstein, Benjamin I.
MacQueen, Glenda
Wang, JianLi
Kennedy, Sidney H.
Addington, Jean
Lebel, Catherine
- License Information
-
More Information
Article History
Accepted: 25 October 2024
First Online: 8 November 2024
Declarations
:
: The study was approved by the University of Calgary conjoint health research ethics board (REB 14–1710) and the ethics committee at the Sunnybrook Health Sciences Centre (REB 100–2015). All participants provided written informed consent and the study was conducted in compliance with the Declaration of Helsinki (World Medical Association, ).
: Not applicable.
: Authors PDM, MKS, XL, ML, RS, SB, BIG, JW, and CL report no biomedical financial interests or potential conflicts of interest. JA has received research support from National Institute of Mental Health, Brain Canada and the Mathison Centre at the University of Calgary. SHK has received funding or honoraria from Abbott, Alkermes, Allergan, AstraZeneca, BMS, Brain Cells Inc., Brain Canada, Clera, CIHR, Eli Lilly, Janssen, Lundbeck, Lundbeck Institute, OMHF, Ontario Brain Institute, Otsuka, Pfizer, Servier, St. Jude Medical, Sunovion and Xian-Janssen. GMM has been on advisory board or speaker for Allergen, Lundbeck, Lilly, Pfizer, Janssen, Johnson & Johnson.
